April 25 (Reuters) - Transition Therapeutics Inc TTH.TO
* Transition therapeutics announces dosing of first patient
in phase 2 study of drug candidate tt701
Source text for Eikon: ID:nPn1Y4GYFa
Further company coverage: TTH.TO
(Bengaluru Newsroom: +1-646-223-8780)